Jennifer Tousignant
Consejero General en VIRIDIAN THERAPEUTICS, INC. .
Perfil
Jennifer Tousignant is currently the Chief Legal Officer at Viridian Therapeutics, Inc. She previously worked as the Senior Vice President-Legal at Sana Biotechnology, Inc. and as a Member-Global Launch Teams at Genzyme Corp.
In addition, she served as the Head-Legal at Xilio Therapeutics, Inc. in 2020 and as the Chief Intellectual Property Counsel at Tesaro, Inc. from 2016 to 2019.
Ms. Tousignant completed her undergraduate studies at the University of Virginia and obtained a graduate degree from Suffolk University Law School.
Cargos activos de Jennifer Tousignant
| Empresas | Cargo | Inicio |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Consejero General | 15/02/2024 |
Antiguos cargos conocidos de Jennifer Tousignant.
| Empresas | Cargo | Fin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Consejero General | 01/11/2020 |
| TESARO INC | Consejero General | 01/10/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| SANA BIOTECHNOLOGY, INC. | Consejero General | - |
Formación de Jennifer Tousignant.
| Suffolk University Law School | Graduate Degree |
| University of Virginia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Tousignant